FOXC2 Antibody

中文名稱：

FOXC2兔多克隆抗體
貨號：

CSB-PA857880LA01HU
規(guī)格：

￥440
圖片：
Immunohistochemistry of paraffin-embedded human brain tissue using CSB-PA857880LA01HU at dilution of 1:100

Immunohistochemistry of paraffin-embedded human breast cancer using CSB-PA857880LA01HU at dilution of 1:100
其他：

產(chǎn)品詳情
產(chǎn)品評價
相關(guān)產(chǎn)品
靶點詳情

產(chǎn)品詳情

產(chǎn)品名稱：

Rabbit anti-Homo sapiens (Human) FOXC2 Polyclonal antibody
Uniprot No.：

Q99958
基因名：

FOXC2
別名：

Drosphilia Forkhead Homolog Like 14 antibody; FKHL 14 antibody; FKHL14 antibody; Forkhead Box C2 antibody; Forkhead box protein C2 antibody; Forkhead related protein FKHL14 antibody; Forkhead-related protein FKHL14 antibody; FOX C2 antibody; Foxc2 antibody; FOXC2_HUMAN antibody; LD antibody; Mesenchyme fork head protein 1 antibody; Mesenchyme Forkhead 1 antibody; MFH 1 antibody; MFH 1 protein antibody; MFH-1 protein antibody; MFH1 antibody; Transcription factor FKH 14 antibody; Transcription factor FKH-14 antibody
宿主：

Rabbit
反應(yīng)種屬：

Human
免疫原：

Recombinant Human Forkhead box protein C2 protein (24-294AA)
免疫原種屬：

Homo sapiens (Human)

標(biāo)記方式：

Non-conjugated

本頁面中的產(chǎn)品，F(xiàn)OXC2 Antibody (CSB-PA857880LA01HU)，的標(biāo)記方式是Non-conjugated。對于FOXC2 Antibody，我們還提供其他標(biāo)記。見下表：

標(biāo)記方式	貨號	產(chǎn)品名稱	應(yīng)用
HRP	CSB-PA857880LB01HU	FOXC2 Antibody, HRP conjugated	ELISA
FITC	CSB-PA857880LC01HU	FOXC2 Antibody, FITC conjugated
Biotin	CSB-PA857880LD01HU	FOXC2 Antibody, Biotin conjugated	ELISA

克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
產(chǎn)品提供形式：

Liquid
應(yīng)用范圍：

ELISA, IHC

推薦稀釋比：

Application	Recommended Dilution
IHC	1:20-1:200

Protocols：

ELISA Protocol
Immunohistochemistry (IHC) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價

靶點詳情

功能：

Transcriptional activator. Might be involved in the formation of special mesenchymal tissues.
基因功能參考文獻(xiàn)：
1. that FOXC2 could promote the invasion ability of normal trophoblast cells by epithelial-mesenchymal transition -mediated Hedgehog pathway PMID: 29465790
2. REVIEW: current understanding of FOXC2 and provide potential mechanistic explanations of the relationship between FOXC2 and cancer, as well as discuss the prospect for future research in the promising prognostic value of FOXC2 in cancer PMID: 29341903
3. The finding of rare LAMA5 variants together with FOXC2 mutations in lymphedema-distichiasis syndrome suggests that these mutations may be co-responsible for these disorders and most likely interfere with the function of lymphatics. PMID: 29908552
4. In FOXC2 knockdown cell lines, CXCR4, a downstream target of FOXC2, can restore osteosarcoma cell invasiveness and metastasis to the lung PMID: 27634875
5. Knockdown of FOXC2 inhibited HCC cell growth, migration, and invasion in vitro, as well as tumor growth. PMID: 29131008
6. Studied interactions between protein kinase C alpha (PKCalpha), FOXC2, and p120-catenin (CTNND1) in breast cancer, cell migration/ invasion; found PKCalpha acts as an upstream regulator of FOXC2, which in turn represses the expression of p120-catenin, in both in endocrine resistant ER+breast cancer and basal A triple negative breast cancer. PMID: 29216867
7. FOXC2 and CLIP4 activity correlates to the presence of PMID: 27283491
8. either a complete loss or a significant gain of FOXC2 function can cause a perturbation of lymphatic vessel formation leading to lymphedema. PMID: 27276711
9. Association of polymorphisms near the FOXC2 gene with the risk of varicose veins in ethnic Russians. PMID: 26420053
10. respectively. Foxc2 is expressed in the developing kidney and therefore congenital renal anomalies may well be associated, potentially as a low penetrance feature. We propose that all individuals diagnosed with Lymphedema distichiasis syndrome should have a baseline renal ultrasound scan at diagnosis PMID: 28544699
11. This is the first report of a FOXC2 mutation in hereditary distichiasis in the Chinese population. The findings expand the FOXC2 mutation spectrum and contribute to the understanding of the genotype-phenotype correlation of this disease. PMID: 27570485
12. FOXC2 promoted the glycolysis in progression of nasopharyngeal carcinoma by activating YAP signaling PMID: 28433696
13. Authors concluded that the lncRNA FOXC2-AS1 may promote doxorubicin resistance in OS by increasing the expression of transcription factor FOXC2, further facilitating ABCB1 expression. PMID: 28323030
14. we demonstrate that FOXC2 is an important determinant of PCa stem-cell attributes, dictating the biochemical shift to ADT- and chemo-resistance PMID: 26804168
15. our data demonstrate that FOXC2 regulates EMT, stem cell traits, ZEB1 expression and metastasis in a p38-dependent manner, and attest to the potential utility of p38 inhibitors as antimetastatic agents. PMID: 27292262
16. Moreover, PLK1 activity is important for FOXC2 protein stability, since PLK1 inhibition reduces FOXC2 protein levels. PMID: 27064522
17. Data suggest that forkhead box protein C2 (FOXC2) could be a potential therapeutic target for overcoming cisplatin (CDDP) resistance in ovarian cancer. PMID: 27336949
18. High expression of FOXC2 is associated with pancreatic ductal adenocarcinoma. PMID: 26733175
19. FOXC2 promotes epithelial-mesenchymal transition, migration and invasion in cisplatin-resistant human ovarian cancer cells. PMID: 27562816
20. Evaluation of FoxC2 expression, alone or in combination with E-cadherin expression, may help to stratify non-small cell lung cancer patients for risk of disease progression, pointing to this EMT regulator as a potential prognostic marker PMID: 26758745
21. Data indicate the role for altered forkhead box C2 (FoxC2)-Delta-like ligand 4 (Dll4)signaling in structural alterations of saphenous veins in patients with varicose veins. PMID: 26808710
22. FOXC2 gene is associated with the glycolipid metabolic abnormality in T2DM patients. PMID: 27349002
23. Adenovirus-mediated FoxC2 expression enhances BMP7-facilitated anabolism in nucleus pulposus cells of the intervertebral discs. PMID: 26824865
24. The data indicate that the expression of FOXC2 in podocytes needs to be tightly regulated, and that its overexpression induces a chain of cellular events leading to podocyte dysfunction. PMID: 26524507
25. Peri-tumoral lymphatics were associated with increased lymphatic metastasis. FOXC2 may be associated with the genesis of endometrial carcinoma and lymphangiogensis in endometrial adenocarcinoma in intra- and peri-tumoral lymphatics. PMID: 26125751
26. our findings contribute to the putative targets in which the FLT4 gene mutation was found to have a significant role in lymphatic filariasis, while FOXC2 and FLT4 SNP interactions need to be further elucidated at a functional level. PMID: 26091406
27. High FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma. PMID: 25573594
28. In cultured lymphatic endothelial cells, FOXC2 inactivation conferred abnormal shear stress sensing, promoting junction disassembly and entry into the cell cycle. This was mediated by TAZ and led to cell death. PMID: 26389677
29. we propose that Foxc2 is functionally maintained in the cytoplasm of normal epithelial cells by CK2alpha/alpha'-mediated phosphorylation at serine 124, which is dependent on proper targeting of the holoenzyme via the CK2b regulatory subunit. PMID: 25486430
30. Twist and Foxc2 stromal expression in PTs was significantly correlated with tumour grade and worse histological features. PMID: 25677742
31. The study defines the requirement of FOXC2 for phosphate-induced osteopontin (OPN) expression and secretion from cancer cells as necessary for the angiogenic response. PMID: 24700685
32. FOXC2 expression was positively correlated with MET expression in CRC tissue samples. PMID: 25381815
33. High expression of forkhead box protein C2 is related to gliomas. PMID: 25605149
34. Results show that GD3S regulates stem cell function via c-Met and the expression of GD3S is regulated by FOXC2, a transcription factor functioning downstream of several epithelial-mesenchymal transition signaling pathways. PMID: 25109336
35. targeting FOXC2 may provide a novel strategy for overcoming chemoresistance in nasopharyngeal carcinoma therapy. PMID: 25896630
36. SENP3, which is increased in gastric cancer cells, potentiates the transcriptional activity of FOXC2 through de-SUMOylation, in favor of the induction of specific mesenchymal gene expression in gastric cancer metastasis. PMID: 25216525
37. It was concluded that there is a significant association between FOXC2 and the metastasis of invasive breast cancer. PMID: 25480587
38. we found a novel missense mutation of C.370C>T in a family with lymphoedema-distichiasis syndrome, which caused an amino acid change from leucine to phenylalanine (p.Leu124Phe). PMID: 24984567
39. FOXC2 may promote the development of cervical cancer via regulation of angiogenesis. PMID: 25556265
40. FOXC2 or its associated gene expression program may provide an effective target for anti-EMT-based therapies PMID: 24700112
41. Results suggested that Prox1 and FOXC2 play key roles in OSCC progression and that further studies focusing on these proteins may yield useful insights for diagnosis and therapy of OSCC. PMID: 24647631
42. FOXC2 gene expression increases with malignancy, especially with blood vessel hyperplasia and invasion degree. Targeted silencing was associated with reduced cell proliferation as well as invasion potential. PMID: 24641373
43. Suggest that FOXC2 plays an essential role in colorectal cancer progression and may serve as a valuable clinical prognostic marker of this disease. PMID: 25069037
44. Seven sporadic SEDAC subjects had no FOXC2 mutations, no symptoms of LDS, and showed differing clinical characteristics from those who had FOXC2 mutations, suggesting that other gene(s) besides FOXC2 are likely to be involved in SEDAC PMID: 24278289
45. FOXC2 contributes to a poor prognosis and cancer progression in extrahepatic cholangiocarcinoma. PMID: 23919841
46. FOXC2 is indispensable for all stages of lymphatic valve development [review] PMID: 24276887
47. FoxC2 and p120ctn play important roles in the progression and prognosis of gastric cancer. PMID: 23614500
48. Results indicate the pivotal role of phosphorylation in the regulation of FOXC2-mediated transcription in lymphatic endothelial cells. PMID: 23878394
49. FOXC2 or its associated gene expression program may provide an effective target for anti-EMT-based therapies for the treatment of claudin-low/basal B breast tumors or other EMT-/CSC-enriched tumors PMID: 23378344
50. de novo mutations and rare variants in hypoplastic left heart syndrome for FOXC2 gene PMID: 21457232
顯示更多

收起更多
相關(guān)疾病：

Lymphedema-distichiasis (LYD)
亞細(xì)胞定位：

Nucleus.
數(shù)據(jù)庫鏈接：

HGNC: 3801

OMIM: 153400

KEGG: hsa:2303

STRING: 9606.ENSP00000326371

UniGene: Hs.436448

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VIM Recombinant Monoclonal Antibody

Applications: ELISA, IHC, IF

Species Reactivity: Human
VDR Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human